Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche synthesizes new TLR antagonists

May 25, 2020

Chinese investigators divulge coagulation factor XIa inhibitors

May 25, 2020

Beijing Tide Pharmaceutical patents ROCK2 inhibitors

May 25, 2020

FDA accepts IND application for phase I/II study of NT-219 in advanced cancer

May 25, 2020

Daiichi Sankyo presents new 5-HT2A receptor agonists

May 25, 2020

Positive data from outpatient portion of a phase II study of RTU glucagon

May 25, 2020

RDIF and ChemRar launch final stage of favipiravir study in patients with COVID-19

May 25, 2020

Lasting immunity to SARS-CoV-2 looks possible

May 25, 2020

SIRPa blockade wakes up macrophages after infection

May 25, 2020

Optimized benzoxazolone carboxamides for oral treatment of neurological lysosomal storage diseases

May 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...